PCSK9 and cancer: Furthermore, we found that MAPK signaling pathway was involved in the PCSK9-induced cancer promotion and that the silencing of PCSK9 impeded the phosphorylation of p38 MAPK, ERK1/2, and JNK, thus significantly downregulating the migration and invasion of cells.